One assay,
endless possibilities

What is CETSA? 

CETSA®(Cellular Thermal Shift Assay) is our patented core technology and is a cell-based approach that measures shifts in a protein’s thermal stability when a compound binds to it. As the temperature rises, proteins unfold. Binding can stabilize a target and shift its apparent melting behavior. In CETSA, samples are heated across a gradient, and the remaining soluble protein is quantified. This yields a thermal profile that reflects engagement. Results come from temperature-dependent denaturation curves read by immunodetection or mass spectrometry, without engineering tags or overexpressing proteins. This can all be summarized in four simple steps:

CETSA at a glance  

Real biology

Measures compound–target binding in intact cells or lysates 

Label and tag-free

Measures native targets-no tags or overexpression needed

One solution for every stage

Supports decisions from target discovery to preclinical studies 

CETSA can be applied in every step of the drug discovery value chain, and no matter which cellular matrix you choose, we generate biologically relevant data that helps you prioritize and confirm drug candidates faster.

Intellectual Property

Pelago Bioscience was founded to provide and develop the patented Cellular Thermal Shift Assay (CETSA) in 2013. The CETSA method is patented in most regions worldwide (IP documentation).​

Read the paper that introduced CETSA

The original CETSA study introducing the approach and that lead to the founding of Pelago Bioscience: Science, 2013 

See CETSA in action

See examples of how CETSA can be used to progress drug discovery projects

Why cellular target engagement matters

Many early choices are made on purified systems that do not reflect real cellular conditions. CETSA brings cell context into those choices. Teams use it to: 

Confirm that hits reach and bind the intended target in a cellular environment 

Rank compounds within a chemotype using comparable engagement metrics 

Support mechanism-of-action claims with evidence from native systems 

Avoid advancing compounds that look strong in vitro but show weak engagement in cells 

Where CETSA fits in the pipeline 

Discovery: See how proteins behave in real cells, and turn complex biology into clear, actionable insights.


Lead generation: Confirm engagement for prioritized hits and guide chemistry toward viable series 

Lead optimization: Track potency shifts and structure–activity trends using thermal profiles 

Preclinical research: Examine selectivity and potential off-targets in complex samples

Let’s talk

For us, every project is a partnership.
Send us a message or book a free scoping call with one of our experts.